ASEP Medical Holdings Inc

As of June 30, 2026, ASEP Medical Holdings Inc carries a market capitalization of 1.09M, placing it among publicly traded companies globally. Its enterprise value stands at 2.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, ASEP Medical Holdings Inc has 15.87M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.97, and the price-to-book ratio stands at 0.58.

These figures are as of June 30, 2026. The EV/Sales ratio of 11.34 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.36M versus a market cap of 1.09M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, ASEP Medical Holdings Inc maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.09, indicating elevated leverage, while an interest coverage ratio of -106.55 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, ASEP Medical Holdings Inc recorded an income tax benefit of -33,304.58 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -4.08M and -2.54M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, ASEP Medical Holdings Inc's stock has declined approximately 78.60% over the past 52 weeks.

Over the twelve months ended June 30, 2026, ASEP Medical Holdings Inc generated 207,705.28 in revenue and converted that into -2.54M in net income, yielding earnings per share of -0.34. EBITDA reached -2.51M, while operating income came in at -1.32M.

As of June 30, 2026, ASEP Medical Holdings Inc holds 47,072.33 in cash and equivalents against 125,352.29 in total debt, resulting in a net debt position of 78,279.96. Total book value stands at 1.88M, with working capital of -1.04M providing operational flexibility.

ASEP Medical Holdings Inc produced -760,572.49 in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -760,572.49 - equivalent to -0.06 per share.

Over the twelve months ended June 30, 2026, ASEP Medical Holdings Inc posted a gross margin of 84.49, reflecting its pricing power and cost economics. The operating margin of -635.97 and net profit margin of -1,223.05 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -92.20: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -29.35, meaning ASEP Medical Holdings Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

ASEP Medical Holdings Inc's most recent stock split took place on April 17, 2025 with a 10:1 split ratio.

As of June 30, 2026, ASEP Medical Holdings Inc has an Altman Z-Score of -23.75, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.